Selenium supplementation for asthma
- PMID: 15106206
- PMCID: PMC9007145
- DOI: 10.1002/14651858.CD003538.pub2
Selenium supplementation for asthma
Abstract
Background: Selenium deficiency may be important in chronic asthma. Observational studies have demonstrated that patients with chronic asthma may have lower levels of selenium than their control. Nevertheless, selenium supplementation has not been recommended with drug therapy for asthma. This review systematically examines RCTs that evaluated the role of selenium supplementation in chronic asthma.
Objectives: Recognition that chronic asthma can be associated with selenium deficiency has led to the investigation of the role of selenium supplementation in reducing the symptoms and impact of chronic asthma. The objective of this review was to assess the efficacy of selenium supplementation as an adjunct to medication for the treatment of chronic asthma.
Search strategy: We searched the Cochrane Airways Group trials register, MEDLINE/PUB MED, and EMBASE. Searches were current as of August 2003.
Selection criteria: Randomised trials comparing patients with chronic asthma receiving selenium supplementation in conjunction with asthma medication, with patients taking asthma medication only.
Data collection and analysis: Two reviewers applied the study inclusion criteria
Main results: One trial with a total of 24 patients suffering from chronic asthma was included. The study reported significant clinical improvement in the selenium-supplemented group, as compared with the placebo group, in terms of a 'clinical evaluation'. However, this improvement could not be validated by significant changes in separate objective parameters of lung function and airway hyper-responsiveness.
Reviewers' conclusions: There is some indication that selenium supplementation may be a useful adjunct to medication for patients with chronic asthma. This conclusion is limited because of insufficient studies and lack of improvement in the clinical parameters of lung function.
Conflict of interest statement
None known.
Figures
Update of
References
References to studies included in this review
Hasselmark 1993 {published data only}
-
- Hasselmark L, Malmgren R, Zetterstrom O, Unge G. [Selenium supplementation in intrinsic asthma]. Allergy 1993;48(1):30‐6. - PubMed
References to studies excluded from this review
Fenech 1998 {published data only}
-
- Fenech AG, Ellul‐Micallef R. [Selenium, glutathione peroxidase and superoxide dismutase in maltese asthmatic patients: effect of glucocorticoid administration.]. Pulmonary Pharmacology & Therapeutics 1998;11(4):301‐8. - PubMed
Flatt 1990 {published data only}
Gazdik 2002 {published data only}
-
- Gazdik F, Kadrabova J, Gazdikova K. Decreased consumption of corticosteroids after selenium supplementation in corticosteroid‐dependent asthmatics. Bratislavske Lekarske Listy 2002;103(1):22‐5. - PubMed
Hasselmark 1990 {published data only}
-
- Hasselmark L, Malmgren R, Unge G, Zetterstrom O. Lowered platelet glutathione peroxidase activity in patients with intrinsic asthma. Allergy 1990;45(7):523‐7. - PubMed
Jahnova 2002 {published data only}
-
- Jahnova E, Horvathova M, Gazdik F, Weissova S. Effects of selenium supplementation of adhesion molecules in corticosteroid‐dependent asthmatics. Bratislavske Lekarske Listy 2002;103(1):12‐6. - PubMed
Kadrabova 1996 {published data only}
-
- Kadrabova J, Mad'aric A, Kovacikova Z, Podivinsky F, Ginter E, Gazdik F. [Selenium status is decreased in patients with intrinsic asthma]. Biological Trace Elemement Research 1996;52(3):241‐8. - PubMed
Misso 1996 {published data only}
-
- Misso NL, Powers KA, Gillon RL, Stewart GA, Thompson PJ. Reduced platelet glutathione peroxidase activity and serum selenium concentration in atopic asthmatic patients. Clinical Experimental Allergy 1996;26(7):838‐47. - PubMed
Pearson 1991 {published data only}
-
- Pearson DJ, Suarez‐Mendez VJ, Day JP, Miller PF. Selenium status in relation to reduced glutathione peroxidase activity in aspirin‐sensitive asthma. Clinical Experimental Allergy 1991;21(2):203‐8. - PubMed
Shaw 1994 {published data only}
-
- Shaw R, Woodman K, Crane J, Moyes C, Kennedy J, Pearce N. [Risk factors for asthma symptoms in Kawerau children]. New Zealand Medical Journal 1994;107(987):387‐91. - PubMed
Stone 1989 {published data only}
-
- Stone J, Hinks LJ, Beasley R, Holgate ST, Clayton BA. [Reduced selenium status of patients with asthma]. Clinical Science 1989;77(5):495‐500. - PubMed
Additional references
BTS 2003
Clarke 2001
-
- Clarke M, Oxman AD. [Assessment of study quality]. In: Clarke M, Oxman AD editor(s). Cochrane Reviewers Handbook. Vol. 4.1.2 [updated March 2001], Section 4, Oxford: Update Software, 2001.
Greene 1995
-
- Greene LS. [Asthma and oxidant stress: nutritional, environmental, and genetic risk factors]. Journal of the American College of Nutrition 1995;14(4):317‐24. - PubMed
Miller 2001
-
- Miller AL. The etiologies, pathophysiology, and alternative/complementary treatment of asthma. Alternative Medicine Review 2001;6(1):20‐47. - PubMed
Thomson 1977
-
- Thomson CD, Rea HM, Doesburg VM, Robinson MF. Selenium concentrations and glutathione peroxidase activities in whole blood of New Zealand residents. British Journal of Nutrition 1977;37(3):457‐60. - PubMed
Thorling 1986
-
- Thorling EB, Overvad K, Geboers J. Selenium status in Europe‐‐human data. A multicenter study. Annals of Clinical Research 1986;18(1):3‐7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
